Robert Hagemann - 30 Sep 2021 Form 4 Insider Report for ZIMMER BIOMET HOLDINGS, INC. (ZBH)

Role
Director
Signature
/s/ Heather J. Kidwell, Attorney-in-Fact for Robert A. Hagemann (power of attorney previously filed)
Issuer symbol
ZBH
Transactions as of
30 Sep 2021
Net transactions value
$0
Form type
4
Filing time
04 Oct 2021, 17:13:26 UTC
Previous filing
16 Jul 2021
Next filing
20 Dec 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZBH Phantom Stock Units Award $0 +227 +1% $0.000000 22,552 30 Sep 2021 Common Stock 227 $148.37 Direct F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
F3 Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.
F4 Includes 32.375 phantom stock units accrued on July 31, 2021 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.